Table 2.
Univariate and multivariate logistic regression.
Characteristics | Category | Univariate analysis |
Multivarite analysis |
||
---|---|---|---|---|---|
OR (95 % CI) | P value | OR (95 % CI) | P value | ||
Gender | male | Ref | Ref | Ref | Ref |
female | 0.498 (0.223–1.111) | 0.089 | 0.894 (0.3–2.66) | 0.84 | |
Tumor size | ≤3 cm | Ref | Ref | Ref | Ref |
>3 cm | 2.688 (1.611–4.485) | <0.001 | 1.417 (0.488–4.111) | 0.521 | |
Tumor number | 1 | Ref | Ref | Ref | Ref |
>1 | 2.935 (1.694–5.083) | <0.001 | 4.723 (1.924–11.598) | 0.001 | |
Vascular invasion | No | Ref | Ref | Ref | Ref |
Yes | 1.469 (0.921–2.343) | 0.106 | \ | \ | |
BCLC | 0 | Ref | Ref | Ref | Ref |
1 | 3.12 (1.578–6.168) | 0.001 | 1.841 (0.497–6.822) | 0.361 | |
2 | 5.365 (2.109–13.644) | <0.001 | 0.721 (0.124–4.18) | 0.715 | |
3 | 3.816 (1.915–7.606) | <0.001 | 1.34 (0.335–5.367) | 0.679 | |
AFP | ≤400 | Ref | Ref | Ref | Ref |
>400 | 1.427 (0.873–2.332) | 0.156 | \ | \ | |
HBV DNA | ≤1000 | Ref | Ref | Ref | Ref |
>1000 | 2.043 (1.258–3.318) | 0.004 | 1.747 (0.861–3.547) | 0.123 | |
Differentiation | poor | Ref | Ref | Ref | Ref |
moderate | 1.146 (0.58–2.262) | 0.695 | \ | \ | |
well | 1.048 (0.432–2.54) | 0.918 | \ | \ | |
N | \ | 1.178 (1.012–1.37) | 0.034 | 0.931 (0.684–1.266) | 0.647 |
M | \ | 4.84 (1.472–15.909) | 0.009 | 2.367 (0.461–12.151) | 0.302 |
Fibrinogen | \ | 1.34 (1.027–1.749) | 0.031 | 1.178 (0.855–1.623) | 0.317 |
Age | \ | 0.996 (0.977–1.016) | 0.719 | \ | \ |
Plt | \ | 1.001 (0.998–1.004) | 0.663 | \ | \ |
L | \ | 0.946 (0.674–1.327) | 0.746 | \ | \ |
Albumin | \ | 0.962 (0.912–1.015) | 0.155 | \ | \ |
NLR | \ | 1.185 (1–1.405) | 0.05 | 1.219 (0.909–1.633) | 0.185 |
AST | \ | 1.01 (0.998–1.023) | 0.1 | \ | \ |
TB | \ | 0.994 (0.979–1.009) | 0.403 | \ | \ |
GGT | \ | 1.003 (0.999–1.006) | 0.118 | \ | \ |
ALT | \ | 1.004 (0.995–1.012) | 0.375 | \ | \ |
Total cholesterol | \ | 1.098 (0.876–1.375) | 0.417 | \ | \ |
Abbreviation: Plt: platelet; N: neutral granulocyte; L: lymphocyte; M: macrophages; NLR: neutrophils to lymphocyte ratio; TB: total bilirubin; ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: γ-glutamyl transpeptidase; BCLC: Barcelona Clinic Liver Cancer staging classification.